![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 489/12 | |
A61K 31/439 | |||
A61P 25/30 |
(11) | Number of the document | 2552924 |
(13) | Kind of document | T |
(96) | European patent application number | 11715634.9 |
Date of filing the European patent application | 2011-04-04 | |
(97) | Date of publication of the European application | 2013-02-06 |
(45) | Date of publication and mention of the grant of the patent | 2015-09-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/031130 |
Date | 2011-04-04 |
(87) | Number | WO 2011/123863 |
Date | 2011-10-06 |
(30) | Number | Date | Country code |
320514 P | 2010-04-02 | US | |
320522 P | 2010-04-02 | US |
(72) |
STINCHCOMB, Audra, Lynn, US
LI, Guohua, US
BANKS, Stan, Lee, US
HOWARD, Jeffery, Lynn, US
GOLINSKI, Miroslaw, Jerzy, US
|
(73) |
Zynerba Pharmaceuticals, Inc.,
80 W. Lancaster Avenue Suite 300, Devon, PA 19333,
US
|
(54) | TRANSDERMALLY DELIVERABLE OPIOID PRODRUGS, ABUSE-RESISTANT COMPOSITIONS AND METHODS OF USING OPIOID PRODRUGS |
TRANSDERMALLY DELIVERABLE OPIOID PRODRUGS, ABUSE-RESISTANT COMPOSITIONS AND METHODS OF USING OPIOID PRODRUGS |